Cholecystokinin and hypothalamic corticotrophin-releasing factor participate in endotoxin-induced hypophagia

Experimental Physiology

Volumn 96, Issue 4, 2011, Pages 439-450

  Rorato, Rodrigo ^a   Reis, Wagner Luis ^a   Antunes Rodrigues, José ^a   Elias, Lucila Leico Kagohara ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DEVAZEPIDE; ENDOTOXIN; PROTEIN FOS; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; CORTICOSTERONE RELEASE; ENDOTOXEMIA; FOOD INTAKE; HYPOPHAGIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS;

EID: 79952607035     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.056465     Document Type: Article

References (60)

1. Antin J, Gibbs J, Holt J, Young RC & Smith GP (1975). Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol 89, 784-790.
2. Babic T, Townsend RL, Patterson LM, Sutton GM, Zheng H & Berthoud HR (2009). Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway. Am J Physiol Regul Integr Comp Physiol 296, R845-R854.
3. Beinfeld MC (2001). An introduction to neuronal cholecystokinin. Peptides 22, 1197-1200.
4. Buchan AM, Polak JM, Solcia E, Capella C, Hudson D & Pearse AG (1978). Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. Gut 19, 403-407.
5. Butera PC, Briffa CF & Whitaker EE (2004). Devazepide fails to reverse the inhibitory effect of interleukin-1β on food intake in female rats. Physiol Behav 82, 777-783.
6. Calogero AE, Nicolosi AM, Moncada ML, Coniglione F, Vicari E, Polosa P & D'Agata R (1993). Effects of cholecystokinin octapeptide on the hypothalamic-pituitary- adrenal axis function and on vasopressin, prolactin and growth hormone release in humans. Neuroendocrinology 58, 71-76.
7. 125I]d-Tyr25 (Nle28, 31)-CCK 25-33S. Eur J Neurosci 4, 563-573.
8. Chen DY, Deutsch JA, Gonzalez MF & Gu Y (1993). The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364, 718. Neurosci Lett 149, 91-94.
9. Chuluyan HE, Saphier D, Rohn WM & Dunn AJ (1992). Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. Neuroendocrinology 56, 106-111.
10. Dantzer R (2001). Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 933, 222-234.
11. Daun JM & McCarthy DO (1993). The role of cholecystokinin in interleukin-1-induced anorexia. Physiol Behav 54, 237-241.
12. Dayas CV, Buller KM & Day TA (2004). Hypothalamic paraventricular nucleus neurons regulate medullary catecholamine cell responses to restraint stress. J Comp Neurol 478, 22-34.
13. Davison JS & Clarke GD (1988). Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors. Am J Physiol Gastrointest Liver Physiol 255, G55-G61.
14. Della-Fera MA & Baile CA (1979). Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206, 471-473.
15. Dockray GJ (2009). Cholecystokinin and gut-brain signalling. Regul Pept 155, 6-10.
16. Dourish CT, Rycroft W & Iversen SD (1989). Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245, 1509-1511.
17. Ebenezer IS (1990). The effect of intracerebroventricular administration of baclofen on food intake in rats. NeuroReport 1, 73-76.
18. Elias LL, Antunes-Rodrigues J, Elias PC & Moreira AC (1997). Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J Clin Endocrinol Metab 82, 1243-1247.
19. Engblom D, Ek M, Saha S, Ericsson-Dahlstrand A, Jakobsson PJ & Blomqvist A (2002). Prostaglandins as inflammatory messengers across the blood-brain barrier. J Mol Med 80, 5-15.
20. Ericsson A, Kovács KJ & Sawchenko PE (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14, 897-913.
21. Gaykema RP, Daniels TE, Shapiro NJ, Thacker GC, Park SM & Goehler LE (2009). Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling. Brain Res 1294, 61-79.
22. Gibbs J, Young RC & Smith GP (1973). Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84, 488-495.
23. Glatzle J, Kreis ME, Kawano K, Raybould HE & Zittel TT (2001). Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors. Am J Physiol Regul Integr Comp Physiol 281, R222-R229.
24. Hewson G, Leighton GE, Hill RG & Hughes J (1988). The cholecystokinin receptor antagonist L364, 718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br J Pharmacol 93, 79- 84.
25. Hill DR, Campbell NJ, Shaw TM & Woodruff GN (1987). Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J Neurosci 7, 2967-2976.
26. Hotta M, Shibasaki T, Arai K & Demura H (1999). Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res 823, 221-225.
27. Inui A, Inoue T, Sakatani N, Oya M, Morioka H & Baba S (1987). Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog. Brain Res 417, 355-359.
28. Juaneda C, Lafon-Dubourg P, Ciofi P, Sarrieau A, Wenger T, Tramu G & Corio M (2001). CCK mRNA expression in neuroendocrine CRH neurons is increased in rats subjected to an immune challenge. Brain Res 901, 277-280.
29. Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP & Gold PW (1992). Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. Endocrinology 130, 1764-1774.
30. Krahn DD, Gosnell BA, Grace M & Levine AS (1986). CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res Bull 17, 285-289.
31. Kurosawa M, Uvnäs-Moberg K, Miyasaka K & Lundeberg T (1997). Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. J Auton Nerv Syst 62, 72-78.
32. Kushner I (1988). The acute phase response: an overview. Methods Enzymol 163, 373-383.
33. Lal S, Kirkup AJ, Brunsden AM, Thompson DG & Grundy D (2001). Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol 281, G907-G915.
34. Mönnikes H, Lauer G & Arnold R (1997). Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770, 277-288.
35. Moran TH, Ameglio PJ, Schwartz GJ & McHugh PR (1992). Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol Regul Integr Comp Physiol 262, R46-R50.
36. Morley JE, Levine AS & Rowland NE (1983). Minireview. Stress induced eating. Life Sci 32, 2169-2182.
37. Okahata H, Nishi Y, Muraki K, Sumi K, Miyachi Y & Usui T (1985). Gastrin/cholecystokinin-like immunoreactivity in human blood cells. Life Sci 36, 369-373.
38. Palkovits M (1999). Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Front Neuroendocrinol 20, 270-295.
39. Paxinos G & Watson C (1997). The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego .
40. Plata-Salamán CR (1998). Cytokines and feeding. News Physiol Sci 13, 298-304.
41. Pournajafi Nazarloo H, Takao T, Taguchi T, Ito H & Hashimoto K (2003). Modulation of type I IL-1 receptor and IL-1β mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse. J Neuroimmunol 140, 102-108.
42. Reidelberger RD & O'Rourke MF (1989). Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. Am J Physiol 257, R1512-R1518.
43. Ritter RC, Covasa M & Matson CA (1999). Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33, 387-399.
44. Rorato R, Castro M, Borges BC, Benedetti M, Germano CM, Antunes-Rodrigues J & Elias LL (2008). Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons. Horm Behav 54, 134-142.
45. Rorato R, Menezes AM, Giusti-Paiva A, de Castro M, Antunes-Rodrigues J & Elias LL (2009). Prostaglandin mediates endotoxaemia-induced hypophagia by activation of pro-opiomelanocortin and corticotrophin-releasing factor neurons in rats. Exp Physiol 94, 371-379.
46. Sawchenko PE & Swanson LW (1982). Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205, 260-272.
47. Schick RR, Reilly WM, Roddy DR, Yaksh TL & Go VL (1987). Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain Res 418, 20-26.
48. Schwartz DH, Dorfman DB, Hernandez L & Hoebel BG (1988). Cholecystokinin: CCK antagonists in the PVN induce feeding. Effects of CCK in the nucleus accumbens on extracellular dopamine turnover. In Cholecystokinin Antagonists, ed. Wang RY & Schoenfeld R, pp. 285-305. Liss, Alan R. Inc, New York .
49. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG (2000). Central nervous system control of food intake. Nature 404, 661-671.
50. Segreti J, Gheusi G, Dantzer R, Kelley KW & Johnson RW (1997). Defect in interleukin-1β secretion prevents sickness behavior in C3H/HeJ mice. Physiol Behav 61, 873-878.
51. South EH & Ritter RC (1988). Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides 9, 601-12.
52. Swiergiel AH & Dunn AJ (1999). The roles of IL-1, IL-6, and TNFα in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav Immun 13, 252-265.
53. Tabarin A, Diz-Chaves Y, Consoli D, Monsaingeon M, Bale TL, Culler MD, Datta R, Drago F, Vale WW, Koob GF, Zorrilla EP & Contarino A (2007). Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur J Neurosci 26, 2303-2314.
54. Turnbull AV & Rivier CL (1999). Regulation of the hypothalamic-pituitaryadrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79, 1-71.
55. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W & Sawchenko PE (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428, 191-212.
56. Verbalis JG, Stricker EM, Robinson AG & Hoffman GE (1991). Cholecystokinin activates C-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J Neuroendocrinol 3, 205-213.
57. 3H]-SR 27897B: a selective probe for autoradiographic labelling of CCK-A receptors in the brain. J Recept Signal Transduct Res 16, 93-113.
58. Zhang X, Fogel R & Renehan WE (1999). Stimulation of the paraventricular nucleus modulates the activity of gut-sensitive neurons in the vagal complex. Am J Physiol Gastrointest Liver Physiol 277, G79-G90.
59. Zhang YH, Lu J, Elmquist JK & Saper CB (2000). Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord. J Neurosci 20, 6578-6586.
60. Zittel TT, Glatzle J, Kreis ME, Starlinger M, Eichner M, Raybould HE, Becker HD & Jehle EC (1999). C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats. Brain Res 846, 1-11.